tiprankstipranks
Black Diamond Therapeutics (BDTX)
NASDAQ:BDTX
US Market

Black Diamond Therapeutics (BDTX) Financial Statements

Compare
1,446 Followers

Black Diamond Therapeutics Financial Overview

Black Diamond Therapeutics's market cap is currently $91.23M. The company's EPS TTM is $-1.27; its P/E ratio is ―; Black Diamond Therapeutics is scheduled to report earnings on March 12, 2025, and the estimated EPS forecast is $0.10. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ -437.00K$ -3.24M$ -2.22M$ -600.00K
Operating Income$ -78.78M$ -86.46M$ -92.83M$ -126.87M$ -69.57M
EBITDA$ -78.78M$ -86.02M$ -92.32M$ -126.67M$ -66.65M
Net Income$ -69.68M$ -82.44M$ -84.52M$ -123.20M$ -65.48M
Balance Sheet
Cash & Short-Term Investments$ 98.58M$ 131.40M$ 122.81M$ 209.79M$ 315.07M
Total Assets$ 122.64M$ 158.57M$ 156.25M$ 247.68M$ 329.67M
Total Debt$ 18.78M$ 25.30M$ 28.14M$ 28.46M$ 8.74M
Net Debt$ -17.66M$ -30.92M$ -6.17M$ -37.34M$ -25.86M
Total Liabilities$ 39.35M$ 41.83M$ 40.56M$ 491.50M$ 21.91M
Stockholders' Equity$ 83.28M$ 116.74M$ -334.99M$ -243.82M$ -118.22M
Cash Flow
Free Cash Flow$ -62.30M$ -66.75M$ -85.27M$ -102.86M$ -52.29M
Operating Cash Flow$ -62.30M$ -66.72M$ -85.08M$ -100.15M$ -52.15M
Investing Cash Flow$ 16.97M$ 16.35M$ 53.37M$ 130.61M$ -281.69M
Financing Cash Flow$ 25.55M$ 71.93M$ 177.00K$ 729.00K$ 214.94M
Currency in USD

Black Diamond Therapeutics Earnings and Revenue History

Black Diamond Therapeutics Debt to Assets

Black Diamond Therapeutics Cash Flow

Black Diamond Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis